栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/07/10 | 2,071 | 2,071 | 2,036 | 2,037 | -41 | -2% | 118,300 |
2025/07/09 | 2,100 | 2,112 | 2,071 | 2,078 | -6 | -0.3% | 115,100 |
2025/07/08 | 2,087 | 2,104 | 2,074 | 2,084 | +9 | +0.4% | 99,100 |
2025/07/07 | 2,089 | 2,099 | 2,071 | 2,075 | -5 | -0.2% | 81,700 |
2025/07/04 | 2,101 | 2,104 | 2,061 | 2,080 | -20 | -1% | 59,400 |
2025/07/03 | 2,123 | 2,123 | 2,072 | 2,100 | -28 | -1.3% | 116,300 |
2025/07/02 | 2,120 | 2,143 | 2,113 | 2,128 | +13 | +0.6% | 88,800 |
2025/07/01 | 2,131 | 2,131 | 2,097 | 2,115 | -16 | -0.8% | 79,300 |
2025/06/30 | 2,151 | 2,152 | 2,126 | 2,131 | -2 | -0.1% | 109,300 |
2025/06/27 | 2,124 | 2,150 | 2,115 | 2,133 | +17 | +0.8% | 105,500 |
2025/06/26 | 2,148 | 2,154 | 2,103 | 2,116 | -40 | -1.9% | 107,300 |
2025/06/25 | 2,169 | 2,202 | 2,127 | 2,156 | +32 | +1.5% | 227,600 |
2025/06/24 | 2,154 | 2,158 | 2,106 | 2,124 | -6 | -0.3% | 94,400 |
2025/06/23 | 2,074 | 2,133 | 2,061 | 2,130 | +57 | +2.7% | 117,200 |
2025/06/20 | 2,108 | 2,111 | 2,073 | 2,073 | -38 | -1.8% | 140,100 |
2025/06/19 | 2,114 | 2,135 | 2,105 | 2,111 | +1 | ±0% | 63,300 |
2025/06/18 | 2,124 | 2,138 | 2,102 | 2,110 | -19 | -0.9% | 151,700 |
2025/06/17 | 2,179 | 2,187 | 2,128 | 2,129 | -71 | -3.2% | 136,800 |
2025/06/16 | 2,172 | 2,213 | 2,170 | 2,200 | +44 | +2% | 173,400 |
2025/06/13 | 2,190 | 2,203 | 2,146 | 2,156 | -7 | -0.3% | 266,500 |
2025/06/12 | 2,092 | 2,170 | 2,092 | 2,163 | +60 | +2.9% | 99,400 |
2025/06/11 | 2,026 | 2,110 | 2,015 | 2,103 | +68 | +3.3% | 117,300 |
2025/06/10 | 2,026 | 2,046 | 2,025 | 2,035 | +5 | +0.2% | 76,000 |
2025/06/09 | 2,015 | 2,036 | 2,011 | 2,030 | +10 | +0.5% | 67,400 |
2025/06/06 | 2,019 | 2,024 | 2,002 | 2,020 | +8 | +0.4% | 70,200 |
2025/06/05 | 2,002 | 2,036 | 1,994 | 2,012 | -3 | -0.1% | 83,000 |
2025/06/04 | 2,001 | 2,029 | 2,001 | 2,015 | +29 | +1.5% | 87,300 |
2025/06/03 | 1,998 | 2,000 | 1,972 | 1,986 | -15 | -0.7% | 99,100 |
2025/06/02 | 2,019 | 2,023 | 1,996 | 2,001 | -40 | -2% | 98,800 |
2025/05/30 | 2,019 | 2,062 | 2,007 | 2,041 | +17 | +0.8% | 152,500 |
2025/05/29 | 2,008 | 2,026 | 2,001 | 2,024 | +19 | +0.9% | 85,100 |
2025/05/28 | 2,037 | 2,038 | 2,004 | 2,005 | -6 | -0.3% | 81,600 |
2025/05/27 | 2,002 | 2,020 | 1,992 | 2,011 | +9 | +0.4% | 59,000 |
2025/05/26 | 2,027 | 2,032 | 1,994 | 2,002 | +2 | +0.1% | 67,200 |
2025/05/23 | 2,006 | 2,015 | 1,992 | 2,000 | +13 | +0.7% | 108,800 |
2025/05/22 | 2,000 | 2,022 | 1,980 | 1,987 | -13 | -0.7% | 190,300 |
2025/05/21 | 2,020 | 2,031 | 2,000 | 2,000 | -15 | -0.7% | 94,400 |
2025/05/20 | 2,031 | 2,046 | 2,014 | 2,015 | ±0 | ±0% | 127,600 |
2025/05/19 | 2,005 | 2,038 | 2,005 | 2,015 | +15 | +0.8% | 87,800 |
2025/05/16 | 2,005 | 2,024 | 1,994 | 2,000 | +3 | +0.2% | 119,300 |
2025/05/15 | 2,050 | 2,070 | 1,995 | 1,997 | -86 | -4.1% | 167,300 |
2025/05/14 | 2,182 | 2,182 | 2,047 | 2,083 | -141 | -6.3% | 259,200 |
2025/05/13 | 2,203 | 2,240 | 2,170 | 2,224 | +29 | +1.3% | 192,100 |
2025/05/12 | 2,231 | 2,231 | 2,174 | 2,195 | -35 | -1.6% | 78,400 |
2025/05/09 | 2,228 | 2,261 | 2,203 | 2,230 | +24 | +1.1% | 147,900 |
2025/05/08 | 2,206 | 2,220 | 2,190 | 2,206 | -4 | -0.2% | 103,800 |
2025/05/07 | 2,221 | 2,230 | 2,206 | 2,210 | -12 | -0.5% | 76,400 |
2025/05/02 | 2,227 | 2,253 | 2,221 | 2,222 | +5 | +0.2% | 73,100 |
2025/05/01 | 2,215 | 2,231 | 2,204 | 2,217 | +2 | +0.1% | 55,700 |
2025/04/30 | 2,211 | 2,230 | 2,197 | 2,215 | -19 | -0.9% | 94,200 |
1~
50
件表示中 / 6993件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 203,700円 | +4.1% | -3.1% | 2.85% | 17.66倍 | 1.54倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 148,600円 | -2.4% | -52.3% | 3.84% | 17.79倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 87,300円 | +20.3% | - | 0.00% | 154.79倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 59,400円 | +14.3% | - | 3.37% | 24.13倍 | 1.54倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ハートシード | 332,000円 | +174.2% | - | 0.00% | - | 9.96倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
市場注目の銘柄
チャート関連のコラム